Page last updated: 2024-12-06
lead tungstate
Description
Lead tungstate (PbWO4), also known as PWO, is an inorganic compound that is highly dense and has a high refractive index. It is a bright yellow solid that is insoluble in water but soluble in acids. Lead tungstate is commonly used as a scintillator material, which means it emits light when exposed to ionizing radiation. This property makes it valuable in medical imaging, high-energy physics experiments, and nuclear security applications. Lead tungstate is synthesized through a variety of methods, including precipitation from aqueous solutions, hydrothermal synthesis, and solid-state reactions. Its synthesis often involves the reaction of lead salts with tungstate salts. Lead tungstate is studied because of its promising properties for various applications, including:
* Its high density and high refractive index make it suitable for use in scintillation detectors for high-energy physics experiments, such as those at the Large Hadron Collider (LHC).
* Its ability to efficiently convert X-rays into visible light makes it valuable for medical imaging, particularly in computed tomography (CT) scanners.
* Its high stopping power for gamma rays makes it useful in nuclear security applications, such as the detection of radioactive materials.
* Its excellent radiation hardness allows it to withstand high doses of radiation, making it ideal for use in harsh environments.
Lead tungstate is a versatile material with numerous applications that continue to be explored in scientific research.'
lead tungstate: used in Raman lasers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 24464 |
MeSH ID | M0460608 |
Synonyms (15)
Synonym |
natural raspite |
lead wolframate |
tungstic acid, lead(2+) salt (1:1) |
lead tungsten oxide (pbwo4) |
lead tungsten tetraoxide |
7759-01-5 |
lead tungstate(vi) |
lead tungstate(iv) |
natural stolzite |
einecs 231-849-7 |
hsdb 643 |
lead tungstate |
Q883696 |
dioxido(dioxo)tungsten;lead(2+) |
DTXSID20896962 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.63
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 31.63 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.42 (4.65) | Search Engine Demand Index | 33.89 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |